Medical marijuana patients in the state might have access to stronger THC products
While it is true that tetrahydrocannabinol (THC) is the psychoactive compound in the cannabis plant, its effects have proven to be more than beneficial in treating various human conditions. Because of this, a bill introduced in the North Dakota Senate seeks to give medical marijuana patients access to a higher THC purchase limit.
Senator Kristin Roers unveiled Senate Bill 2068 before the Senate Judiciary Committee yesterday. Under the proposal, the limit of THC that medical cannabis patients can purchase in a 30-day period would be increased. That is, they would no longer be subject to purchasing only 4,000 mg, but that amount would be doubled to 8,000 mg. Although THC is what gives marijuana users a high, different researchers have considered it one of the most effective compounds to treat a great diversity of diseases.
According to Roers, the legislation strives to address differences in the amounts of THC in the vast array of products on the state market. As a result, it could be key to steer patients away from dried leaves and flowers to manufactured products, which he said have a consistent dose of THC.
According to Roers, the amounts of THC can be variable such that buying two of the same item would exceed the 4,000-milligram limit for patients who prefer certain manufactured products. By increasing the limit set by current law, patients would no longer have to worry about this type of issue when purchasing their products. The committee did not take immediate action on the bill, but further updates are expected in the coming weeks.